Shutdown pain ripples through US economy with no deal in sight
(Bloomberg) — The first week of a government shutdown is usually the easy one. It only gets harder after that.
As the standoff between President Donald Trump and Congress stretches into its second week — and with no end in sight — the real-world impacts of the shutdown are starting to rise.
» Read more about: Shutdown pain ripples through US economy with no deal in sight »
Read MoreUS government shutdown begins to undermine the country's economy
On the 11th day of the United States federal government shutdown,
» Read more about: US government shutdown begins to undermine the country's economy »
Read MoreBetter Nuclear Energy Stock: Cameco vs. Oklo
Nuclear energy is gaining traction and stocks in the industry are surging. When it comes to Cameco versus Oklo, one stands out as a better stock today.
Goldman Sachs reports that data centers, powering the innovative artificial intelligence (AI) algorithms, could cause power demand from data centers to increase by 165% by 2030.
» Read more about: Better Nuclear Energy Stock: Cameco vs. Oklo »
Read MoreChina 'not afraid' of trade war amid rare earths dispute with US
Chinese authorities signaled Sunday that Beijing would not back down in the face of a 100% tariff threat from U.S. President Donald Trump, urging Washington to resolve differences through negotiations instead of threats.
Beijing called Trump’s latest tariffs on Chinese goods hypocritical and defended its curbs on exports of rare earth elements and equipment,
» Read more about: China 'not afraid' of trade war amid rare earths dispute with US »
Read MoreDelicate trade truce with China hangs in the balance after export controls
WASHINGTON (TNND) — The tenuous pause in the trade war between the United States and China may be at risk of breaking open again after Beijing implemented new restrictions on its exports of rare earth metals and other products that provoked a threat of a return of steep tariffs to Chinese products that roiled financial markets and prompted concerns about the economy.
» Read more about: Delicate trade truce with China hangs in the balance after export controls »
Read MoreThe Burst
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
Nvidia’s Drop Might Be Your Once-in-a-Decade Opportunity
When markets panic, great companies go on sale and that’s exactly what’s happening with Nvidia right now.
Amid escalating tariff skirmishes and a broader tech pullback, the world’s most important AI company has seen its stock fall nearly 19.9% from its 2025 highs. But don’t let the noise distract you.
Beneath the surface,
» Read more about: Nvidia’s Drop Might Be Your Once-in-a-Decade Opportunity »
Read MoreThe Spotlight
Is Apple’s Dip The Perfect Buying Opportunity?
Apple has fallen by almost 15% from nearly $200 per share in recent months. The decline appeared to precede the major market averages more recent correction but does it bode ominously for Apple or has the recent pullback offered new buyers an opportunity to get in on a great company at sale prices?
In the near-term,
» Read more about: Is Apple’s Dip The Perfect Buying Opportunity? »